Fiscal Period | 2024 | 2023 |
---|---|---|
Period End Date | Mar 24 | Mar 23 |
Net Income/ Starting Line | -5.66 | 0.05 |
Depreciation/ Depletion | 1.71 | 1.88 |
Non- Cash Items | 0.00 | -0.19 |
Changesin Working Capital | 3.75 | -1.41 |
Cashfrom Operating Activities | -0.19 | 0.33 |
Capital Expenditures | -1.59 | -0.94 |
Cashfrom Investing Activities | -1.59 | -0.94 |
Issuance( Retirement)of Debt Net | 1.43 | -0.04 |
Cashfrom Financing Activities | 1.43 | -0.04 |
Net Changein Cash | -0.35 | -0.65 |
Cash Taxes Paid | 0.12 | 0.00 |
Parmax Pharma Dividend Parmax Pharma Bonus Parmax Pharma News Parmax Pharma AGM Parmax Pharma Rights Parmax Pharma Splits Parmax Pharma Board Meetings Parmax Pharma Key Metrics Parmax Pharma Shareholdings Parmax Pharma Profit Loss Parmax Pharma Balance Sheet Parmax Pharma Q1 Results Parmax Pharma Q2 Results Parmax Pharma Q3 Results Parmax Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks